Population Genetics Gets Funding under International Leukemia Study | GenomeWeb

NEW YORK (GenomeWeb News) – Population Genetics said today that it has received funding to support a European-backed international research consortium studying genetic risk among children for relapse of acute lymphoblastic leukemia, or ALL.

Funded with €6 million ($7.5 million) from the European Commission, the five-year effort, called the IntReALL consortium, will engage 23 research teams seeking to develop a standardized treatment for this malignant childhood disease, an effort that will involve gathering, banking, and studying DNA from Europe, Japan, Israel, and Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.